Table 4.
Marker | Groups | 1st Immunization | 2nd Immunization |
---|---|---|---|
CD4+/CD3+ | PBS buffer | 18.27 ± 0.21 a | 19.47 ± 3.21 a |
pET-32a tag protein | 20.90 ± 1.64 a | 23.28 ± 1.62 a | |
rEmROM5 | 27.75 ± 1.35 bc | 30.07 ± 0.57 b | |
PBS buffer | 10.18 ± 0.87 a | 14.13 ± 1.50 a | |
pVAX1.0 | 11.50 ± 2.05 a | 16.45 ± 2.05 a | |
pVAX-EmROM5 | 22.57 ± 1.85 b | 27.51 ± 4.95 b | |
CD8+/CD3+ | PBS buffer | 21.45 ± 0.72 a | 22.80 ± 5.20 a |
pET-32a tag protein | 22.37 ± 1.53 a | 25.93 ± 3.39 a | |
rEmROM5 | 35.20 ± 5.20 b | 43.59 ± 6.76 b | |
PBS buffer | 13.00 ± 1.65 a | 13.78 ± 1.61 a | |
pVAX1.0 | 15.60 ± 1.13 b | 17.24 ± 0.42 a | |
pVAX-EmROM5 | 22.37 ± 0.17 c | 31.40 ± 4.48 b |
a–c Means in the same columns marked with the same letter indicates that the difference between treatments is not significant (p > 0.05). Means in the same columns marked with a different letter indicates a significant difference between treatments (p < 0.05).